Federal Register of Legislation - Australian Government

Primary content

PB 73 of 2013 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) by removing the listed drug tiaprofenic acid from F1.
Administered by: Health
Made 14 Oct 2013
Registered 16 Oct 2013
Tabled HR 12 Nov 2013
Tabled Senate 12 Nov 2013
Date of repeal 02 Nov 2013
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

 

PB 73 of 2013

 

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health , delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                  14         October 2013

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 6).

         (2)   This Determination may also be cited as PB 73 of 2013.

2              Commencement

                This Determination commences on 1 November 2013.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Tiagabine

 

Omit

 

Tiaprofenic acid